Floatz logo

POLO-LIKE KINASE 1 INHIBITOR NMS-1286937

Advanced or Metastatic Solid Tumors

Nerviano Medical SciencesSmall moleculePhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
73/ 100

Competitive context

62 Active assets in the Advanced or Metastatic Solid Tumors cohort.

Asset / SponsorPhaseRating
Pembrolizumab
Hanmi Pharmaceutical Company Limited
Phase 1/2B
Epirubicin
Hanmi Pharmaceutical Company Limited
Phase 1/2B
Cyclophosphamide
Beijing Biotech
Phase 1/2B
Eloxatin
ASLAN Pharmaceuticals
Phase 1/2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
Merck Sharp & Dohme LLC
Phase 1/2CCC

View all 50 →

Same molecule, other indications

POLO-LIKE KINASE 1 INHIBITOR NMS-1286937 is also rated in:

pancreatic ductal adenocarcinomaDormant
B
Indicative ·
60 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
58 / 100
View asset →
malignant pancreatic neoplasmDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →